Switch to:

Corvus Pharmaceuticals EV-to-Revenue

: (As of Today)
View and export this data going back to 2016. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Corvus Pharmaceuticals's enterprise value is $54.52 Mil. Corvus Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $0.00 Mil. Therefore, Corvus Pharmaceuticals's EV-to-Revenue for today is .

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-10-23), Corvus Pharmaceuticals's stock price is $3.96. Corvus Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $0.00. Therefore, Corvus Pharmaceuticals's PS Ratio for today is .


Corvus Pharmaceuticals EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corvus Pharmaceuticals Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corvus Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Corvus Pharmaceuticals EV-to-Revenue Distribution

* The bar in red indicates where Corvus Pharmaceuticals's EV-to-Revenue falls into.



Corvus Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Corvus Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=54.522/0
=

Corvus Pharmaceuticals's current Enterprise Value is $54.52 Mil.
Corvus Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) = $0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Corvus Pharmaceuticals  (NAS:CRVS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Corvus Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=3.96/0
=

Corvus Pharmaceuticals's share price for today is $3.96.
Corvus Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) = $0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Corvus Pharmaceuticals EV-to-Revenue Related Terms


Corvus Pharmaceuticals EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)